ArticleOncotarget2014

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.

Hatem H Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.